跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CD20-targeted CAR-T
首页
药物
CD20-targeted CAR-T
CD20-targeted CAR-T
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
CD19 and CD20 targeting combined chimeric antigen receptor and application thereof
CN 115955974 A
申请人: CELLULAR BIOMEDICINE GROUP INC
优先权: 2021
CN
Chimeric antigen receptor (CAR) and preparation method thereof
CN 116003636 A
申请人: CHENGDU WANJUNHUA BIOLOGICAL TECH CO LTD
优先权: 2023
CN
Application of mitochondrial transcription factor TFAM in targeting CD20 and CD19 double-target chimeric antigen receptor and CAR-T cell
CN 121949563 A
申请人: TIANYIKANG MEDICINE SHANGHAI CO LTD
优先权: 2025
CN
Preparation method and application of double-target CAR-T cell targeting CD19 and CD20
CN 121472156 A
申请人: AFFILIATED TONGJI HOSPITAL OF TONGJI MEDICAL COLLEGE OF HUAZHONG UNIV SCI & TECH
优先权: 2025
CN
药物
反馈